skip to main content

Bin Wang, Ph.D. Joins the Hamilton Brook Smith Reynolds Life Sciences Team

June 27, 2019

June 27, 2019, Concord and Boston, MA - Leading intellectual property law firm Hamilton Brook Smith Reynolds is pleased to announce that Bin Wang, Ph.D. has joined the firm as an Associate. Bin is a patent attorney specializing in the areas of biotechnology, life sciences, and pharmaceuticals. Bin also has experience with U.S. and foreign trademark prosecution.

Alice Carroll, Principal, Hamilton Brook Smith Reynolds, stated, “Bin’s scientific depth and experience in patent law will complement our life science practice.  Her awards and academic honors reflect her depth of knowledge, hard work and talent.  We are pleased to introduce Bin to our life science clients and we welcome her to the firm.”

Bin has prepared and prosecuted patent applications for small molecule therapeutics, therapeutic polypeptides and antibodies, therapeutic applications of adult stem cells, nanoparticle drug delivery compositions, and cancer diagnostics. Some of Bin’s representative areas of technical focus include: treatment or prevention for neurodegenerative diseases, cancers, ischemic stroke, autoimmune diseases, inflammatory diseases, bone marrow failure, viral infections, preterm labor, mitochondrial neurogastrointestinal encephalomyopathy, uterine contractility disorder, systemic endotoxemia using adult stem cells, steroid hormones, small molecule therapeutics, kinase inhibitors, modulator of cytokine, anti-aging agent, fungal etiologic agents, splice variants, cell-free DNA, RNAi silencing molecules, antibodies, erythrocytes, and dual targeting anti-cancer strategy.

Bin’s has experience in diagnostics and prognostics for traumatic brain injury, adrenocortical carcinoma, neurodegenerative diseases, and liver diseases, using whole genome sequencing, bioinformatics, microRNA markers, and breath test. Additionally, Bin’s experience includes methods of detecting genomic rearrangements, detecting heteroresistant pathogens, and distinguishing somatic versus germline variants in impure tumors.

Prior to joining the firm, Bin served as a judicial extern as Law Clerk to The Eastern District of Texas, United States District Court Judge K. Nicole Mitchell. After completing her Ph.D., Bin was a Postdoctoral Fellow at Stanford University, a Postdoctoral Fellow and an Assistant Professor of Research at The University of Texas Health Science Center at San Antonio.  Bin has been the recipient of many awards and honors, including the Dean’s Postdoctoral Fellowship from Stanford University, the Dean's Academic Excellence Full Scholarship, Jim Barlow Memorial Award, Loy M. Simpkins Memorial Award, and Thomas M. Featherston, Jr. Estate Planning Award from Baylor Law School, and NIH Individual National Research Service Award.

Bin is the author of over twenty scientific articles and book contributions including: Development, Nature Immunology, Cell, Nature, Journal of General Physiology, Methods in Molecular Biology, American Journal of Physiology-Lung Cellular and Molecular Physiology, Molecular Psychiatry, Human Molecular Genetics, Invertebrate Neuroscience, Experimental Biology, Neuroscience, European Journal of Neuroscience, and Frontiers in Physiology. Bin wrote two book chapters, one for Encyclopedia of Basic Epilepsy Research and the other for Ion Channels, Methods, and Protocols.

Hamilton, Brook, Smith & Reynolds, P.C. is among New England’s largest law firms devoted to the practice of intellectual property law. The firm specializes in patents, trademarks, intellectual property litigation, copyrights, licensing, due diligence, opinions, trade secrets, and intellectual property counseling. The firm’s legal staff provides extensive scientific and technical expertise in biotechnology, chemistry, computer hardware and software, telecommunications, medical devices, pharmaceuticals, physics, optics, nanotechnology, and electrical, chemical and mechanical engineering.